Halop, Bernadette T.
HRN: 00-72-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/29/2023
CEFUROXIME 500MG (TAB)
01/29/2023
02/05/2023
PO
500mg Tab
BID
Post NSVD With RMLE And Repair
Waiting Final Action
Indication: Prophylaxis Type of Infection: BloodstreamReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes